Induction of physical dependence in rats by short interval medication.
Rats were intermittently medicated at one hour intervals through an implanted intravenous cannula. Physical dependence on morphine and codeine was developed rapidly and it was detectable with the maintenance dose as low as 9.6 mg/kg/day. Physical dependence on pentazocine was also developed with the maintenance dose of 96 mg/kg/day, but was not with 9.6 mg/kg/day. In the pentazocine-treated rates, body weight loss was observed after the abrupt withdrawal, and abstinence signs were precipitated by naloxone 1 mg/kg. Cross physical dependence between morphine and pentazocine was demonstrated. Pentazocine suppressed the abstinence signs of rats weakly dependent on morphine, and morphine suppressed those of pentazocine-dependent rats. ID-1229, a new benzomorphan analgesic, did not produce dependence in this test and did not suppress the abstinence signs of morphine- and pentazocine-dependent rats.
D000818:Animals; D001575:Benzomorphans / Q000008:administration & dosage / Q000031:analogs & derivatives; D003061:Codeine / Q000008:administration & dosage; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004347:Drug Interactions; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009020:Morphine / Q000008:administration & dosage; D009021:Morphine Dependence; D009294:Narcotics / Q000008:administration & dosage*; D010423:Pentazocine / Q000008:administration & dosage; D051381:Rats; D013375:Substance Withdrawal Syndrome; D019966:Substance-Related Disorders
D001575:Benzomorphans; D009294:Narcotics; C010823:ID 1229; D009020:Morphine; D010423:Pentazocine; D003061:Codeine